Samjo Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Buy
+32,000
New +$184K 0.06% 56
2024
Q4
Sell
-1,044,800
Closed -$8.07M 57
2024
Q3
$8.07M Buy
1,044,800
+265,295
+34% +$2.36M 2.78% 8
2024
Q2
$7.8M Buy
779,505
+214,062
+38% +$2.35M 2.9% 7
2024
Q1
$6.87M Buy
565,443
+154,543
+38% +$2.24M 2.42% 9
2023
Q4
$5.88M Buy
+410,900
New +$3.94M 2.08% 9

Other funds holding OPRX

Samjo Management's OPRX Position: Q2 2026 in Review

Samjo Management opened a new position in OptimizeRx (OPRX) in Q2 2026: 32,000 shares worth $183K. The stake represents 0.06% of the portfolio and ranks #56 among its holdings. This is a return to the name: Samjo Management previously reported a position in OPRX as recently as Q3 2024.

Samjo Management first reported a position in OPRX in Q4 2023 and has held it in 5 quarters since. The position peaked at $8.07M in Q3 2024. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Samjo Management held 32,000 shares of OptimizeRx worth $183K as of Q2 2026.
  • OptimizeRx was a new Samjo Management position in Q2 2026.
  • OptimizeRx made up 0.06% of Samjo Management's portfolio in Q2 2026, its #56 holding.
  • Samjo Management first reported a position in OptimizeRx in Q4 2023 and has held it in 5 quarters since.
  • Samjo Management's OptimizeRx position peaked at $8.07M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Samjo Management's 13F filing for Q2 2026, filed 14 Aug 2026.